[HTML][HTML] Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature

JK Bender, V Cattoir, K Hegstad, E Sadowy… - Drug Resistance …, 2018 - Elsevier
Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens. Invasive VRE
infections are difficult to treat since common therapeutic options including ampicillin and …

The action mechanism of daptomycin

SD Taylor, M Palmer - Bioorganic & medicinal chemistry, 2016 - Elsevier
Daptomycin is a lipopeptide antibiotic produced by the soil bacterium Streptomyces
roseosporus that is clinically used to treat severe infections with Gram-positive bacteria. In …

A highly efficacious electrical biofilm treatment system for combating chronic wound bacterial infections

F Zhao, Y Su, J Wang, S Romanova… - Advanced …, 2023 - Wiley Online Library
Biofilm infection has a high prevalence in chronic wounds and can delay wound healing.
Current treatment using debridement and antibiotic administration imposes a significant …

Resistance in vancomycin-resistant enterococci

WR Miller, BE Murray, LB Rice… - Infectious Disease Clinics, 2020 - id.theclinics.com
The genus Enterococcus consists of facultative gram-positive cocci that have been isolated
from a variety of animals, plants, and environmental sources. Although 58 species have …

Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall

AS Bayer, T Schneider, HG Sahl - … of the New York Academy of …, 2013 - Wiley Online Library
The bactericidal, cell membrane–targeting lipopeptide antibiotic daptomycin (DAP) is an
important agent in treating invasive Staphylococcus aureus infections. However, there have …

Daptomycin

M Heidary, AD Khosravi, S Khoshnood… - Journal of …, 2018 - academic.oup.com
Daptomycin is a cyclic lipopeptide antibiotic used for the treatment of Gram-positive
infections including complicated skin and skin structure infections, right-sided infective …

Mechanisms of drug resistance: daptomycin resistance

TT Tran, JM Munita, CA Arias - … of the New York Academy of …, 2015 - Wiley Online Library
Daptomycin (DAP) is a cyclic lipopeptide with in vitro activity against a variety of Gram‐
positive pathogens, including multidrug‐resistant organisms. Since its introduction into …

Molecular engineering of antimicrobial peptides: Microbial targets, peptide motifs and translation opportunities

P Cardoso, H Glossop, TG Meikle, A Aburto-Medina… - Biophysical …, 2021 - Springer
The global public health threat of antimicrobial resistance has led the scientific community to
highly engage into research on alternative strategies to the traditional small molecule …

Mechanism of action and resistance to daptomycin in Staphylococcus aureus and enterococci

WR Miller, AS Bayer, CA Arias - Cold Spring …, 2016 - perspectivesinmedicine.cshlp.org
Lipopeptides are natural product antibiotics that consist of a peptide core with a lipid tail with
a diverse array of target organisms and mechanisms of action. Daptomycin (DAP) is an …

A current perspective on daptomycin for the clinical microbiologist

RM Humphries, S Pollett… - Clinical microbiology …, 2013 - Am Soc Microbiol
Daptomycin is a lipopeptide antimicrobial with in vitro bactericidal activity against Gram-
positive bacteria that was first approved for clinical use in 2004 in the United States. Since …